Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00725153 · ClinicalTrials.gov registry record · NA
Evaluation of Deposits on Contact Lenses Worn Daily Wear
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT00725153 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 55 participants.
The verdict
NCT00725153, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study was to measure front surface deposits on contact lenses when worn for ten hours.
Interventions
- DEVICE Balafilcon A contact lenses (PureVision)
- DEVICE Etafilcon A contact lenses (Acuvue2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00725153
The ClinicalTrials.gov registry entry for NCT00725153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Balafilcon A contact lenses (PureVision) is the first listed.
NCT00725153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00725153 about?
NCT00725153 is a clinical study titled "Evaluation of Deposits on Contact Lenses Worn Daily Wear". The purpose of this study was to measure front surface deposits on contact lenses when worn for ten hours.
What is the current status of trial NCT00725153?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2008-03. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00725153?
The interventions under investigation include: Balafilcon A contact lenses (PureVision) (DEVICE), Etafilcon A contact lenses (Acuvue2) (DEVICE).
Who is sponsoring clinical trial NCT00725153?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.